SALT LAKE CITY, UT--(Marketwire - October 23, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer, Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
